- Home
- AIG vs A Comparison
AIG vs A Comparison
Compare AIG & A Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIG
- A
- Stock Information
- Founded
- AIG 1919
- A 1999
- Country
- AIG United States
- A United States
- Employees
- AIG N/A
- A N/A
- Industry
- AIG Life Insurance
- A Biotechnology: Laboratory Analytical Instruments
- Sector
- AIG Finance
- A Industrials
- Exchange
- AIG Nasdaq
- A Nasdaq
- Market Cap
- AIG 46.4B
- A 38.6B
- IPO Year
- AIG N/A
- A 1999
- Fundamental
- Price
- AIG $83.62
- A $116.70
- Analyst Decision
- AIG Buy
- A Buy
- Analyst Count
- AIG 15
- A 13
- Target Price
- AIG $83.47
- A $151.50
- AVG Volume (30 Days)
- AIG 6.1M
- A 2.1M
- Earning Date
- AIG 04-30-2025
- A 02-26-2025
- Dividend Yield
- AIG 1.91%
- A 0.85%
- EPS Growth
- AIG N/A
- A 4.31
- EPS
- AIG N/A
- A 4.36
- Revenue
- AIG $27,027,000,000.00
- A $6,533,000,000.00
- Revenue This Year
- AIG $0.32
- A $5.84
- Revenue Next Year
- AIG $4.79
- A $6.23
- P/E Ratio
- AIG $24.99
- A $26.77
- Revenue Growth
- AIG N/A
- A N/A
- 52 Week Low
- AIG $69.00
- A $116.36
- 52 Week High
- AIG $85.11
- A $155.35
- Technical
- Relative Strength Index (RSI)
- AIG 60.82
- A 29.80
- Support Level
- AIG $83.30
- A $117.92
- Resistance Level
- AIG $85.11
- A $124.43
- Average True Range (ATR)
- AIG 1.70
- A 2.97
- MACD
- AIG -0.13
- A 0.26
- Stochastic Oscillator
- AIG 73.35
- A 4.15
About AIG American International Group Inc. New
American International Group is one of the largest insurance and financial services firms in the world and has a global footprint. It operates through a wide range of subsidiaries that provide property, casualty, and life insurance. The company recently spun off its life insurance operations (Corebridge), but still retains a majority stake.
About A Agilent Technologies Inc.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.